Home
  >  
Section 81
  >  
Chapter 80,083

Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics

Mohammed, A.O.; Abo-Idrees, M.I.; Makki, A.A.; Ibraheem, W.; Alzain, A.A.

Structural Chemistry 33(5): 1553-1567

2022

ISSN/ISBN: 1040-0400
PMID: 35789829
Accession: 080082813
Download citation:  
Text
  |  
BibTeX
  |  
RIS
A virus called severe acute respiratory distress syndrome coronavirus type 2 (SARS-CoV-2) is the causing organism of coronavirus disease 2019 (COVID-19), which has severely affected human life and threatened public health. The pandemic took millions of lives worldwide and caused serious negative effects on human society and the economy. SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp) are interesting targets due to their crucial role in viral replication and growth. Since there is only one approved therapy for COVID-19, drug repurposing is a promising approach to finding molecules with potential activity against COVID-19 in a short time and at minimal cost. In this study, virtual screening was performed on the ChEMBL library containing 9923 FDA-approved drugs, using various docking filters with different accuracy. The best drugs with the highest docking scores were further examined for molecular dynamics (MD) studies and MM-GBSA calculations. The results of this study suggest that nadide, cangrelor and denufosol are promising potential candidates against COVID-19. Further in vitro, preclinical and clinical studies of these candidates would help to discover safe and effective anti-COVID-19 drugs.

PDF emailed within 1 workday: $29.90




Related References

Indu, P.; Rameshkumar, M.R.; Arunagirinathan, N.; Al-Dhabi, N.A.; Valan Arasu, M.; Ignacimuthu, S. 2020: Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: a molecular docking and drug repurposing approach Journal of Infection and Public Health 13(12): 1856-1861
Omer, S.E.; Ibrahim, T.M.; Krar, O.A.; Ali, A.M.; Makki, A.A.; Ibraheem, W.; Alzain, A.A. 2022: Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations Biochemistry and Biophysics Reports 29: 101225
Arun, K.G.; Sharanya, C.S.; Abhithaj, J.; Francis, D.; Sadasivan, C. 2020: Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target Journal of Biomolecular Structure and Dynamics 2020: 1-12
Matondo, A.; Dendera, W.; Isamura, B.K.; Ngbolua, K.-T.-N.; Mambo, H.V.S.; Muzomwe, M.; Mudogo, V. 2022: In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies Advances and Applications in Bioinformatics and Chemistry: Aabc 15: 59-77
de Souza, A.Silva.; de Souza, R.Francisco.; Guzzo, C.Rodrigues. 2021: Quantitative structure-activity relationships, molecular docking and molecular dynamics simulations reveal drug repurposing candidates as potent SARS-CoV-2 main protease inhibitors Journal of Biomolecular Structure and Dynamics 2021: 1-18
Jalalvand, A.; Khatouni, S.B.; Najafi, Z.B.; Fatahinia, F.; Ismailzadeh, N.; Farahmand, B. 2021: Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method Journal of Basic and Clinical Physiology and Pharmacology 33(1): 85-95
Jalalvand, A.; Khatouni, S.B.; Najafi, Z.B.; Fatahinia, F.; Ismailzadeh, N.; Farahmand, B. 2021: Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method Journal of Basic and Clinical Physiology and Pharmacology 33(1): 85-95
Kumar, Y.; Singh, H.; Patel, C.N. 2020: In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing Journal of Infection and Public Health 13(9): 1210-1223
Rai, H.; Barik, A.; Singh, Y.P.; Suresh, A.; Singh, L.; Singh, G.; Nayak, U.Y.; Dubey, V.K.; Modi, G. 2021: Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19 Molecular Diversity 25(3): 1905-1927
Azam, F.; Eid, E.E.M.; Almutairi, A. 2021: Targeting SARS-CoV-2 main protease by teicoplanin: a mechanistic insight by docking, MM/GBSA and molecular dynamics simulation Journal of Molecular Structure 1246: 131124
Sargolzaei, M. 2021: Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study Journal of Molecular Graphics and Modelling 103: 107803
Hussien, M.A.; Abdelaziz, A.E.M. 2020: Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease Network Modeling and Analysis in Health Informatics and Bioinformatics 9(1): 56
Vishvakarma, V.K.; Singh, M.B.; Jain, P.; Kumari, K.; Singh, P. 2022: Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations Amino Acids 54(2): 205-213
Vijayakumar, M.; Janani, B.; Kannappan, P.; Renganathan, S.; Al-Ghamdi, S.; Alsaidan, M.; Abdelaziz, M.A.; Peer Mohideen, A.; Shahid, M.; Ramesh, T. 2022: In silico identification of potential inhibitors against main protease of SARS-CoV-2 6LU7 from Andrographis panniculata via molecular docking, binding energy calculations and molecular dynamics simulation studies Saudi Journal of Biological Sciences 29(1): 18-29
El Hassab, M.A.; Shoun, A.A.; Al-Rashood, S.T.; Al-Warhi, T.; Eldehna, W.M. 2020: Identification of a new Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations Frontiers in Chemistry 8: 584894
Parvez, M.S.A.; Karim, M.A.; Hasan, M.; Jaman, J.; Karim, Z.; Tahsin, T.; Hasan, M.N.; Hosen, M.J. 2020: Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach International Journal of Biological Macromolecules 163: 1787-1797
Dutta, K.; Elmezayen, A.D.; Al-Obaidi, A.; Zhu, W.; Morozova, O.V.; Shityakov, S.; Khalifa, I. 2021: Seq12, Seq12m, and Seq13m, peptide analogues of the spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico study through molecular docking, molecular dynamics simulation, and MM-PB/GBSA calculations Journal of Molecular Structure 1246: 131113
Khater, I.; Nassar, A. 2021: In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease Biochemistry and Biophysics Reports 27: 101032
Hakmi, M.; Bouricha, E.M.; Kandoussi, I.; Harti, J.E.; Ibrahimi, A. 2020: Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis Bioinformation 16(4): 301-306
Lazniewski, M.; Dermawan, D.; Hidayat, S.; Muchtaridi, M.; Dawson, W.K.; Plewczynski, D. 2022: Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations Methods 203: 498-510